Riskpilot← Back to searchSign inGet full accessINCUMEDIC AS
ASActiveOrg 924000554Rødmyrlia 2, 3735 SkienEconomic activity was not specified by tax authority · NACE 0000Est. 20190 employees
Revenue 2024
NOK 0
EBITDA margin
—
-485% vs 2023
Equity ratio
60.3%
Financial strength
Net profit 2024
NOK -345K
-1300% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -334K | -485% |
| Net profit | NOK -345K | -1300% |
| Total assets | NOK 5M | -3% |
| Equity | NOK 3M | -10% |
| Employees | 0 | — |
Legal name
INCUMEDIC AS
Org number
924000554
Legal form
Aksjeselskap
NACE code
0000 · Economic activity was not specified by tax authority
Founded
3. desember 2019
Share capital
NOK 40 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Investering i aksjer og andre eierandeler i andre selskaper og foretak, samt all annen virksomhet som hermed står i forbindelse.
Address
Rødmyrlia 2, 3735 Skien
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 300 | 300 | 300 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 0 | −166 | −310 | −223 | 87 | −334 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | 0 | −166 | −310 | −223 | 87 | −334 |
| Net financials | 0 | 0 | 18 | −0 | −58 | −12 |
| Profit before tax | 0 | −166 | −291 | −223 | 29 | −345 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | 0 | −166 | −291 | −223 | 29 | −345 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | 30 | 6 385 | 4 991 | 4 628 | 5 159 | 4 981 |
| Equity | 30 | 3 834 | 3 543 | 3 320 | 3 349 | 3 004 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 2 551 | 1 448 | 1 308 | 1 810 | 1 977 |
| Total debt | 0 | 2 551 | 1 448 | 1 308 | 1 810 | 1 977 |
EBITDA margin
-33352300.0%
This company
15.8%
Market median
-211090606% vs market
20192024
Equity ratio
60.3%
This company
38.2%
Market median
+58% vs market
20192024
Return on equity
-11.5%
This company
18.4%
Market median
-163% vs market
20192024
Net profit margin
-34531600.0%
This company
8.1%
Market median
-426316149% vs market
20192024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20192024
Debt / equity
0.66×
This company
0.62×
Market median
+6% vs market
20192024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-11-04 – 2019-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2021 | — | — | |
| Board of Directors | 2021 | — | — |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of INCUMEDIC AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Birger Tufte Johansen | Chairman | 0 companies |
| Philippe Caers | Board of Directors | 0 companies |